Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.
- Resource Type
- Article
- Authors
- Hagiwara, Akifumi; Oughourlian, Talia C; Cho, Nicholas S; Schlossman, Jacob; Wang, Chencai; Yao, Jingwen; Raymond, Catalina; Everson, Richard; Patel, Kunal; Mareninov, Sergey; Rodriguez, Fausto J; Salamon, Noriko; Pope, Whitney B; Nghiemphu, Phioanh L; Liau, Linda M; Prins, Robert M; Cloughesy, Timothy F; Ellingson, Benjamin M
- Source
- Neuro-Oncology; Jun2022, Vol. 24 Issue 6, p1020-1028, 9p
- Subject
- Language
- ISSN
- 15228517